Maintenance Therapy With Trabectedin Versus Observation After First Line Treatment With Doxorubicin of Patients With Advanced or Metastatic Soft Tissue Sarcoma.
Latest Information Update: 17 Sep 2021
Price :
$35 *
At a glance
- Drugs Trabectedin (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 29 Jul 2021 This trial has been completed in Cyprus, according to European Clinical Trials Database record.
- 01 Sep 2020 Status changed from active, no longer recruiting to discontinued.
- 18 Jun 2020 This trial has been discontinued in UK, according to European Clinical Trials Database record.